September 29, 2025 – Alimentiv Inc. (“Alimentiv”) is pleased to announce its participation in the highly anticipated European Gastroenterology Week (UEGW) 2025, taking place from October 4–7 in Berlin, Germany.
This year Alimentiv researchers and collaborators will be presenting four posters at UEG Week 2025, showcasing advancements in the design and conduct of clinical trials in IBD. The posters include:
harmacokinetics of Infliximab Concentrations in Serum and Colonic Mucosa in Acute Severe Ulcerative Colitis (PROTOS Study) | Dr. Robert Battat
Reliability and Responsiveness of Endoscopic Indices for Assessment of Postoperative Recurrence in Crohn’s Disease in the PREVENT Trial | Dr. Jurji Hanzel
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease | Dr. Jurji Hanzel
An International Consensus on the Design of Clinical Trials for Advanced Combination Treatment (ACT) in Inflammatory Bowel Disease | Dr. Virginia Solitano
Connect with Alimentiv’s experts at booth #4.29 and discover how we can help you achieve your project goals.